Diagnosis and treatment of severe hypertriglyceridemia (Q37998115)

26 August 2017

title

Diagnosis and treatment of severe hypertriglyceridemia (English)

1 reference

26 August 2017

1 reference

2

Anthony S Wierzbicki

1 reference

26 August 2017

Adie Viljoen

1

1 reference

26 August 2017

publication date

1 April 2012

1 reference

Expert Review of Cardiovascular Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

10

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

505-514

1 reference

Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia

26 August 2017

cites work

1 reference

Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism

21 January 2018

1 reference

Lipoprotein lipase: genetics, lipid uptake, and regulation.

21 January 2018

1 reference

Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.

21 January 2018

1 reference

Lipoprotein lipase: from gene to obesity

21 January 2018

1 reference

A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency

21 January 2018

1 reference

Molecular pathobiology of the human lipoprotein lipase gene

21 January 2018

1 reference

Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet

21 January 2018

1 reference

Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis

21 January 2018

1 reference

Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia

21 January 2018

1 reference

Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?

21 January 2018

1 reference

APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency

21 January 2018

1 reference

An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients

21 January 2018

1 reference

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons

21 January 2018

1 reference

Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase

21 January 2018

1 reference

Lipase maturation factor LMF1, membrane topology and interaction with lipase proteins in the endoplasmic reticulum

21 January 2018

1 reference

Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.

21 January 2018

1 reference

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

21 January 2018

1 reference

Sortilins: new players in lipoprotein metabolism

21 January 2018

1 reference

Genetics and regulation of angiopoietin-like proteins 3 and 4.

21 January 2018

1 reference

Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events

21 January 2018

1 reference

Clinical practice. Hypertriglyceridemia

21 January 2018

1 reference

Lipid metabolism in pregnancy

21 January 2018

1 reference

Acute pancreatitis in pregnancy: an overview

21 January 2018

1 reference

Drug treatment of combined hyperlipidemia

21 January 2018

1 reference

Unreliability of triglyceride measurement to predict turbidity induced interference

21 January 2018

1 reference

Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach

21 January 2018

1 reference

Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects

21 January 2018

1 reference

Apolipoprotein B-48: comparison of fasting concentrations measured in normolipidaemic individuals using SDS-PAGE, immunoblotting and ELISA.

21 January 2018

1 reference

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

21 January 2018

1 reference

HIV lipodystrophy and its metabolic consequences: implications for clinical practice

21 January 2018

1 reference

Review on anti-lipoprotein lipase antibodies

21 January 2018

1 reference

Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome

21 January 2018

1 reference

Potential options to treat hypertriglyceridaemia

21 January 2018

1 reference

Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations

21 January 2018

1 reference

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

21 January 2018

1 reference

Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis

21 January 2018

1 reference

Therapeutic Response to Medium-Chain Triglycerides and ω-3 Fatty Acids in a Patient With the Familial Chylomicronemia Syndrome

21 January 2018

1 reference

n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution

21 January 2018

1 reference

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

21 January 2018

1 reference

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

21 January 2018

1 reference

Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase

21 January 2018

1 reference

FIELDS of dreams, fields of tears: a perspective on the fibrate trials

21 January 2018

1 reference

Mechanism of action of niacin

21 January 2018

1 reference

Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid

21 January 2018

1 reference

The physiological and molecular regulation of lipoprotein assembly and secretion

21 January 2018

1 reference

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

21 January 2018

1 reference

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

21 January 2018

1 reference

Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.

21 January 2018

1 reference

Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study

21 January 2018

1 reference

A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy

21 January 2018

1 reference

Comparison of Statins in Hypertriglyceridemia

21 January 2018

1 reference

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

21 January 2018

1 reference

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome

21 January 2018

1 reference

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.

21 January 2018

1 reference

The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis

21 January 2018

1 reference

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study

21 January 2018

1 reference

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

21 January 2018

1 reference

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

21 January 2018

1 reference

Usefulness of Orlistat in the treatment of severe hypertriglyceridemia

21 January 2018

1 reference

Rimonabant: endocannabinoid inhibition for the metabolic syndrome

21 January 2018

1 reference

Viruses exploiting peroxisomes

21 January 2018

1 reference

2009 Pandemic H1N1 Influenza Virus Causes Disease and Upregulation of Genes Related to Inflammatory and Immune Responses, Cell Death, and Lipid Metabolism in Pigs

21 January 2018

1 reference

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy

21 January 2018

1 reference

Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates

21 January 2018

1 reference

Lowering apolipoprotein CIII delays onset of type 1 diabetes

21 January 2018

1 reference

Future challenges for microsomal transport protein inhibitors

21 January 2018

1 reference

The role of the microsomal triglygeride transfer protein in abetalipoproteinemia

21 January 2018

1 reference

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

21 January 2018

1 reference

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

21 January 2018

1 reference

CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans

21 January 2018

1 reference

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

21 January 2018

1 reference

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers

21 January 2018

1 reference

Gene therapy for lipoprotein lipase deficiency: working toward clinical application

21 January 2018

1 reference

Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.12.21

1 reference

26 August 2017

1 reference